Empowered Funds LLC Takes Position in Amedisys, Inc. (NASDAQ:AMED)

Empowered Funds LLC purchased a new position in shares of Amedisys, Inc. (NASDAQ:AMED) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 3,500 shares of the health services provider’s stock, valued at approximately $318,000.

Several other large investors have also modified their holdings of the business. Blue Trust Inc. boosted its holdings in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after acquiring an additional 124 shares during the period. HBW Advisory Services LLC purchased a new stake in shares of Amedisys in the fourth quarter valued at about $38,000. Versant Capital Management Inc grew its stake in shares of Amedisys by 68.5% in the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 183 shares during the last quarter. KBC Group NV acquired a new position in Amedisys in the 3rd quarter valued at $63,000. Finally, Signaturefd LLC lifted its position in Amedisys by 20.9% in the third quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock valued at $132,000 after purchasing an additional 236 shares during the period. Institutional investors and hedge funds own 94.36% of the company’s stock.

Analysts Set New Price Targets

Separately, Stephens reiterated an “equal weight” rating and issued a $101.00 price target on shares of Amedisys in a report on Wednesday, February 12th. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Amedisys has an average rating of “Hold” and a consensus target price of $100.75.

Amedisys Price Performance

Shares of NASDAQ:AMED opened at $91.20 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The business’s fifty day moving average price is $90.64 and its two-hundred day moving average price is $93.48. The stock has a market cap of $2.99 billion, a PE ratio of 36.19, a price-to-earnings-growth ratio of 1.83 and a beta of 0.73.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.